This complaint is unable to be confirmed due to the device being discarded by the hospital.These electrodes contain lectron iii 4% gel component and a pe foam component which has been tested for cytotoxicity, sensitization and intracutaneous.A review of device history revealed 4 complaints have been reported in the past two years.During this same two-year time frame, (b)(4) devices have been sold worldwide making the calculated occurrence probability (b)(4).A risk analysis was performed and determined the risk to be acceptable.The ifu states the following to mitigate this potential issue: "select and prepare electrode sites according to your health care facility's protocol for ecg monitoring.The electrode sites should be clean, dry, and free from skin oil prior to electrode application.Check the expiration date on the un-opened pouch of electrodes.Electrodes must be used before expiration date indicated on the package.To minimize skin trauma during electrode removal, lift slowly and gently from the peel tab or electrode edge." to date, there have been no patient long term effects resulting from this reported problem.The reported problem will continue to be monitored through the complaint system to ensure patient/product safety.Device was discarded by user facility.
|
Conmed corporation received a product experience report containing adverse event information from the (b)(6).Symmetrical to the exactrace electrode placement, there was a large red bubbling area on the skin of the thigh.This was primarily interpreted as an allergic reaction.This developed over time and the wound started to develop an infection.The wound became deep and the patient has problems in the form of pain, etc.And still has today.At this time, we have been unable obtain additional patient/event information.
|